Did you know you can place an order for Ozempic sourced from a reliable source in Singapore? While Canadian inventory is limited we offer our customers alternate solutions. Speak to a live agent today.

Save 10% off on your first order with coupon code: FIRST10OFF

Obesity is a growing public health crisis. Millions worldwide continually search for effective ways to manage their weight. In this ongoing battle, a new beacon of hope emerges. It is Zepbound (tirzepatide), a prescription drug. It is drawing much attention for its potential in weight management. This article aims to explore the use of Zepbound for adults with obesity in 2024. It will look at its mechanism of action, potential benefits, and important considerations. The article will offer a full look at how this treatment could revolutionize obesity care.

Understanding Zepbound and Obesity

weighing scale for weight loss ZepBound

Obesity is a complex public health issue. It affects millions globally. It is marked by too much body fat. This fat can lead to severe health problems like diabetes, heart disease, and some cancers. People have long looked for good weight management solutions. This search led to many treatments. One of the most promising is Zepbound (tirzepatide).

What is Zepbound?

It is a new prescription medication. It has garnered attention for its potential to manage obesity. It is a drug that acts in two ways. It targets two critical pathways in the body’s metabolism. These are the glucagon-like peptide-1 (GLP-1) receptor. They are the glucose-dependent insulinotropic polypeptide (GIP) receptor. Activating these receptors enhances the body’s insulin response. It also reduces appetite and promotes a feeling of fullness.

How Does Zepbound Work

Zepbound’s dual-action mechanism is what sets it apart from other weight management drugs. The GLP-1 receptor agonist helps regulate blood sugar. It also slows gastric emptying, which makes you feel full longer after eating. The GIP receptor agonist boosts insulin secretion. It also improves the body’s metabolism. This combination leads to a significant reduction in food intake and, consequently, weight loss.

Benefits of Zepbound for Weight Management

Zepbound (tirzepatide) is becoming a promising prescription for weight management. It offers many benefits for individuals with obesity. Here are the key advantages of using Zepbound:

Appetite Suppression

One of the primary benefits of the weight loss medication is its ability to suppress appetite. It activates the GLP-1 and GIP receptors, which play a crucial role in regulating hunger and satiety signals in the brain. Zepbound enhances these signals. It reduces hunger and cravings, leading to eating fewer calories. Patients using Zepbound often report feeling fuller for longer after meals. This greatly reduces the tendency to overeat or snack on unhealthy foods. This appetite suppression is essential for achieving and maintaining weight loss.

Improved Blood Sugar Control

Zepbound also helps people with obesity. They may have pre-diabetes or type 2 diabetes. Zepbound stimulates insulin secretion. It also improves insulin sensitivity. This helps regulate blood sugar levels better. This two-part mechanism supports weight loss. It also improves glycemic control, reducing the risk of diabetes complications. Controlling blood sugar levels is crucial. It prevents pre-diabetes from turning into type 2 diabetes. It’s also key to managing existing diabetes better.

Potential for Weight Loss

Clinical trials have shown that Zepbound is effective. It promotes significant weight loss when combined with a proper diet and exercise plan. In these studies, Zepbound users lost a lot of weight. This was compared to those getting a placebo. The approach targets both GLP-1 and GIP receptors. It contributes to success by addressing many aspects of metabolism and appetite regulation. The trial results highlight Zepbound’s potential. It is a powerful tool for weight management. It helps people achieve weight loss goals and improve their health.

Important Considerations for Zepbound Use

When considering Zepbound (tirzepatide) for weight management, you must know several key factors. They are essential to ensure its safe and effective use. Here are the important considerations:

FDA Approval Status

As of June 2024, Zepbound is not yet FDA-approved for weight management. While it has shown promise in clinical trials, it is currently under evaluation for this specific indication. Trials are ongoing. They study its safety and effectiveness for weight loss. We expect the results to give more insight into its potential approval for this use.

Potential Side Effects

Like other GLP-1 agonists, it can cause side effects that users should be aware of. Common side effects include nausea, vomiting, diarrhea, and constipation. These stomach issues are usually mild to moderate. They tend to lessen over time as the body gets used to the medication. People must discuss these side effects with their doctor. They need to understand how to manage them well. They also need to find out if Zepbound is a good option based on their health.

Zepbound is a Prescription Medication

It is a prescription medication, meaning it requires a doctor’s approval and supervision. It should not be used without medical guidance. This is to ensure that it is right for the person’s health condition. And, to check for any bad reactions or interactions with other drugs. A healthcare provider can also help tailor the dosage and treatment plan. They do this to maximize benefits and minimize risks.

Lifestyle Changes Remain Crucial

While Zepbound can significantly aid in weight management, it is not a standalone solution. For optimal results, it should be used in conjunction with a healthy diet and regular exercise. You must make these lifestyle changes. They are key for achieving and keeping weight loss. They also improve health and boost the medication’s effectiveness. Managing weight sustainably requires a comprehensive approach. It includes medication, diet changes, and exercise.

Who Might Be a Candidate for Zepbound (if approved)?

If the FDA approves Zepbound (tirzepatide) for weight management, it could become a great treatment for certain people with obesity. Identifying suitable candidates for Zepbound is crucial to ensure its safe and effective use. Here are the key factors that might determine candidacy:

Adults with Obesity

Zepbound is primarily intended for adults with obesity. This typically includes individuals with a Body Mass Index (BMI) of 30 or higher. Obesity has many health risks. These include heart disease, diabetes, and some cancers. So, it’s vital to manage weight well to improve health and cut these risks.

Adults with Overweight and Weight-Related Health Conditions

Their BMI is 27 or higher. They also have at least one weight-related health condition, such as type 2 diabetes, hypertension, or dyslipidemia. They might also be candidates for Zepbound. These conditions make the health risks of overweight and obesity worse. Losing weight can greatly improve health.

Individuals Struggling with Weight Loss through Traditional Methods

Zepbound may help people who have not lost much weight through diet and exercise alone. For those who have not seen good results from lifestyle changes, Zepbound could help them. It would be an extra tool to help them reach their weight goals.

Patients with Type 2 Diabetes

Zepbound’s works by improving glycemic control. It could help people with obesity and type 2 diabetes. By enhancing insulin sensitivity and promoting weight loss, Zepbound can help manage both conditions simultaneously, improving overall metabolic health.

Individuals Committed to a Comprehensive Weight Management Plan

Candidates for the medication should be committed to adding the medication to a broader weight management plan. This plan should include a healthy diet and regular exercise. To manage weight in the long term, you need a holistic approach. You must be willing to adopt and keep up with lifestyle changes while taking the medication.

Those Without Contraindications

Potential candidates should be screened for any contraindications to Zepbound use. This includes people with a history of severe gut diseases. It also includes those with certain hormone disorders. And those who are very sensitive to any parts of the medication. A thorough medical evaluation by a healthcare provider is essential to ensure that Zepbound is safe for use in each case.

Zepbound Dosage

The Zepbound doses are designed to be titrated, meaning they are gradually increased to help the body adjust and to minimize side effects.

Available Dosages

  • 2.5 mg
  • 5 mg
  • 7.5 mg
  • 10 mg
  • 12.5 mg
  • 15 mg

Typical Dosage Schedule

  1. Starting Dose: The initial dose is typically 2.5 mg once weekly. This starting dose is maintained for 4 weeks.
  2. Titration: After the initial period, the dose is gradually increased:
    • Increase to 5 mg once weekly for at least 4 weeks.
    • The dose can be increased by 2.5 mg at a time. This is based on the patient’s blood sugar and what they can tolerate. The most that can be taken each week is 15 mg.

What Is the New Weight Loss Drug in 2024?

Oral Semaglutide

Oral semaglutide is a GLP-1 agonist. It works by copying the effects of GLP-1, a hormone crucial for regulating blood glucose, digestion, and appetite. The medication is taken as a tablet once a day. Novo Nordisk, the maker, has been scrutinizing it for FDA approval for weight management. Notably, results from the phase 3 OASIS 1 study show big weight loss potential. Participants lost up to 15% of their starting weight over about 15 months. This is similar to the weight loss seen with the injectable semaglutide variant, Wegovy.

Amycretin

Oral amycretin is a new medication in development for chronic weight management. It is a dual GLP-1 and amylin agonist. Amylin helps with post-meal fullness. Amycretin is taken once daily in tablet form. An under-the-skin injection is also in development. Amycretin finished a phase 1 trial in December 2023. A phase 2 study will start in late 2024. Early phase 1 data shows promise. Participants lost an average of 13% of their weight over 12 weeks. This suggests amycretin may be as effective as semaglutide.

Orforglipron

Orforglipron is an oral GLP-1 agonist. It differs from injectable forms due to its chemistry, which helps it survive in the stomach. It is taken as a once-daily oral capsule. It is now in a phase 3 study for chronic weight loss in adults. The study began in June 2023 and will go on until mid-2027. Early results from a phase 2 trial suggest promise. Participants could see up to a 15% drop in weight after about 8 months (36 weeks) of use. 

Is Ozempic Better than Zepbound?

Both medications are GLP-1 receptor agonists. They are used for weight management. But, they may differ in how well they work, how safe they are, how often they are dosed, and their side effects.

Trials and real-world data can show how well these drugs work and how safe they are. But, the best choice for an individual depends on their unique situation. Talk to a healthcare provider who knows your medical history and treatment preferences. They can help find the best medication for you.

When Will Zepbound Be Available Again?

It’s hard to get now due to a huge spike in demand. Recent updates say the shortages will last at least through June 2024. But, supply should become more reliable starting in July 2024.

Eli Lilly makes Zepbound. They are working to increase production to meet high demand. All dosages are still being made and shipped. But, demand currently outpaces supply.

For patients looking to manage during this shortage, it may help to ask multiple pharmacies. They can also consider switching to dosages that might be more available. Or, they can explore online pharmacies and fulfillment options. Also, some online tools and communities can help. For example, the Ro GLP-1 Supply Tracker and the Zepbound subreddit on Reddit give updates. They also provide support for finding supplies.

Is Zepbound More Expensive than Wegovy?​

Zepbound and Wegovy are both used for weight management, but they differ in terms of cost. Wegovy’s list price is about $1,349 per month without insurance. But, with insurance, patients may pay as little as $25, depending on their plan​.

Zepbound is generally less expensive. Its out-of-pocket price is about $1,060 per month. For those with commercial insurance, the cost can be cut to as low as $25. This is for a one-month or three-month prescription. Even for those without specific insurance coverage for Zepbound, the price may be as low as $550 per month​​.

So, Zepbound is usually cheaper than Wegovy. But, the costs can vary based on insurance and pharmacy prices.

Zepbound Shortage

The shortage is expected to last until at least July 2024​. Patients struggle to fill prescriptions, especially for higher doses. Mitigation strategies include frequent pharmacy check-ins. You can also try using multiple pharmacies. You can order early refills and seek larger supplies. Eli Lilly is expanding production to meet demand. They aim for better supply by the second half of 2024. Online tools and communities can also help locate available stock during this period.

Is Zepbound Hard to Get?

This shortage affects all dosage strengths except for the 2.5 mg starter dose. The demand for Zepbound has grown faster than the supply. This has made it hard for patients to fill their prescriptions.

To find Zepbound, patients should follow up often with their pharmacy. They should contact many local pharmacies and consider online options. Order refills early and request a three-month supply instead of a monthly one. This can help manage the shortage more effectively. Online tools and communities can provide updates on availability. They can help find pharmacies with stock. Examples include the Ro GLP-1 Supply Tracker and the Zepbound subreddit.

What Is the Difference between Zepbound and Mounjaro?

girl weight loss in ZepBound

ZepBound and Mounjaro are hypothetical names. They represent potential weight management drugs that could have distinct traits. First, they might differ in how they work. This can be true even if they belong to the same class, like GLP-1 receptor agonists. They might interact with GLP-1 receptors or other weight pathways in different ways. This could lead to variations. These variations could cause differences in their effectiveness and safety.

Their unique blends distinguish them from others. One medication might be an oral tablet. It’s convenient for patients who prefer oral drugs. The other could be an injectable. It offers an alternative for those who prefer or need injectables.

Differences in treatment success become apparent during clinical studies. One medication may be better at promoting weight loss than the other. Or, they may differ in their side effects and tolerability. These differences affect which medication is right for each patient. They depend on the patient’s needs and preferences.

Also, safety, cost, and availability would further distinguish ZepBound from Mounjaro. Factors like side effects, contraindications, and manufacturing could impact the drugs. They affect their affordability, accessibility, and suitability for patients. Market competition and insurance coverage are also key.

How Much Does ZepBound Cost

Looking for ZepBound Coupon 2024?

It used for weight loss and diabetes management, typically costs $1,060 per month. Without insurance, it’s that expensive. However, with insurance, some patients may pay as low as $25 per month. Uninsured patients might find it for about $550 per month through specific programs​. Additionally, 365 Script Care is an online pharmacy partner. They offer a ZepBound coupon to cut the cost of the medication. This makes it more affordable. Patients should visit the 365 Script Care website to check for coupons. They should also consult their healthcare provider to ensure it fits their treatment plan.

Is Zepbound More Expensive than Wegovy?

Yes, switching from ZepBound to Wegovy is possible, but it should be done under the guidance of a healthcare provider. Both medications belong to the class of GLP-1 receptor agonists and are used for weight management. However, they have key differences. These include their route of administration and potential side effects. Before you switch, your healthcare provider will assess factors. These include your weight goals, ZepBound tolerance, and medical history. They will use this to see if Wegovy is suitable. They will also guide the transition. This includes any changes in dosing and how to give the drug. They will also consider practical aspects. These include cost and insurance coverage. They want to ensure that the switch works for you. 

ZepBound for Weight Loss

In conclusion, ZepBound has much promise. It could be a treatment for obese adults in 2024. But, ZepBound is a prescription medication. It would be best if you used it under the guidance of a healthcare provider. ZepBound has potential benefits. But, people considering it should also know about its side effects and other issues. For those interested in trying ZepBound as a treatment, it may be for sale from trusted sources. For example, 365 Script Care, an online pharmacy, may have it. ZepBound can help obese adults get healthier. But, only with proper medical supervision and a full weight management approach.

📢 MOUNJARO IS NOW AVAILABLE. It's an alternative to Ozempic. Save up to 70%. Use code 365SCMOUNJARO10OFF for an additional 10% off. Chat now to order!